Considering that melanoma is resistant to anti-PD-1 therapy,43 our data provide new evidence that adoptive cell therapy using Lsp1-edited T cells together with anti-PD-1 blockade might be a promising strategy for more effectively treating solid tumors, such as melanoma. The gene discussed is LSP1; the disease is melanoma.